Genmab A/S 2024 Annual Report with Sustainability Disclosures
Company: Genmab A/S
Sector: Professional & technical services
Country: Denmark
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 205
The report presents Genmab's 2024 consolidated performance, including DKK 21,526 million in revenue and year-end headcount of 2,750. It marks Genmab's first year integrating sustainability disclosures under CSRD/ESRS and reports its first double materiality assessment. The year included the acquisition of ProfoundBio and progression of Rina-S and acasunlimab into Phase 3 development. Genmab also reports a 42% Scope 1 and Scope 2 market-based emissions reduction target by 2030 from a 2024 base year.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.